Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome
The use of small interfering RNAs (siRNAs) has been under investigation for the treatment of several unmet medical needs, including acute lung injury/acute respiratory distress syndrome (ALI/ARDS) wherein siRNA may be implemented to modify the expression of pro-inflammatory cytokines and chemokines...
Saved in:
Main Authors: | Makhloufi Zoulikha (Author), Qingqing Xiao (Author), George Frimpong Boafo (Author), Marwa A. Sallam (Author), Zhongjian Chen (Author), Wei He (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pulmonary endothelium-targeted nanoassembly of indomethacin and superoxide dismutase relieves lung inflammation
by: Yi Yang, et al.
Published: (2023) -
Thermal Stability of siRNA Modulates Aptamer- conjugated siRNA Inhibition
by: Alexey Berezhnoy, et al.
Published: (2012) -
Antibody-siRNA conjugates (ARC): Emerging siRNA drug formulation
by: Weiran Cao, et al.
Published: (2022) -
Protection and Systemic Translocation of siRNA Following Oral Administration of Chitosan/siRNA Nanoparticles
by: Borja Ballarín-González, et al.
Published: (2013) -
Dendrimers for siRNA Delivery
by: Swati Biswas, et al.
Published: (2013)